11 min read
Monthly FDA Guidance and Regulatory News Review - June 2026
This June 2026 regulatory update focuses on advancing innovative drug development through updated guidance on...
Meet Veristat at BIOCHINA & CMAC: Advancing Global Clinical Development
🔬 Connecting with the Global Biotech Community
We are pleased to be attending BIOCHINA, where innovators from across the biotech ecosystem come together to discuss the future of drug development and global regulatory strategy. As more companies pursue international pathways for approval, thoughtful clinical planning and strong data strategies have never been more important. Our team looks forward to engaging with fellow leaders, sharing perspectives, and exploring how we can help advance complex therapies from development to regulatory success.
We are also looking forward to attending the CMAC Annual Meeting and spending time with colleagues across the clinical development ecosystem. It’s so valuable to step away from day-to-day program work and have thoughtful conversations about the evolving challenges in trial design, data strategy, and regulatory expectations. So we’re excited to exchange ideas, share perspectives from complex development programs, and connect with teams advancing the next generation of therapies.
👥 Meet the Veristat Team at BIOCHINA & CMAC
Connect with our experts to explore how Veristat’s tailored solutions can advance your clinical and regulatory milestones:
-
Lorenzo Scalise: Business Development Representative
-
Daphne Smyth: Vice President Regulatory
-
AJ Mills: Executive Vice President
📅 Schedule a meeting in advance
By completing the form on this page. We welcome the opportunity to discuss your upcoming programs and how Veristat can be a strategic partner in your success.
💡 Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
Let’s shape the future of clinical research—together.
Schedule A Meeting
Meet with us at BIOCHINA & CMAC in China March 12-20, 2026
2 min read
FDA Prior Knowledge Guidance: A New Framework for Natural History Evidence
Jul 2, 2026 Veristat Blog
June 22, 2026
What the FDA's prior knowledge guidance means for natural history evidence and shared datasets
On June 2,...